Should I buy Amn Healthcare Services, Inc. (AMN) stock or is it too late?

Amn Healthcare Services, Inc. · Health Care · price $37

See the full Amn Healthcare Services, Inc. (AMN) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $35 (-4.2 %), call made on August 8, 2026, maturing on August 8, 2027 (67 d ago).

The 1 reliable analyst $35-4.2 %

The 4 other firms $40+9.5 %

How to read it: the 1 reliable firms are not filtered by optimism — 0 aim above the price, 1 below, hence their $35 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Amn Healthcare Services, Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
BMO Capital	32 %	-14.4 %	19	$43 +18%
Truist Securities	18 %	-29.7 %	11	$40 +9%
JMP Securities	10 %	-36.0 %	10	$22 -40%
Credit Suisse	62 %	+14.5 %	13	—
Benchmark	43 %	+2.7 %	7	—

In short — Should you invest in Amn Healthcare Services, Inc.? Is it too late, still worth it? Analysts are fairly positive (60% buy, median target $40, i.e. +9%), and the most reliable on AMN targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

60% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
Median price target $40, i.e. +9% from the current price ($37).
The most reliable firm on AMN, BMO Capital (32% hit rate, 19 scored calls), targets $43 (call made on October 9, 2026, maturing on October 9, 2027) (+18%) in its most recent call, and $25 (call made on January 15, 2026, maturing on January 15, 2027) (-32%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 5 ratings, 2 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on AMN

Median target $40 (+9%) · 5 ratings · Buy consensus

Strong Buy00%

Buy360%

Hold240%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Amn Healthcare Services, Inc. now?

We won't decide for you. The facts: 60% of analysts rate it a buy, median target $40 (+9%), and BMO Capital (most reliable on AMN, 32%) targets $43. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Amn Healthcare Services, Inc.?

Not according to analysts: the median target ($40) is still +9% above the current price ($37) (most reliable on AMN: BMO Capital, 32%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Amn Healthcare Services, Inc. still worth investing in?

It depends on the gap between the price ($37) and its estimated value: analysts target $40 on median (+9%), with 60% buys (most reliable on AMN: BMO Capital, 32%). Cross-check with their real reliability on AMN and the cautions above. Information, not advice.

What's the main risk in buying AMN?

The consensus is not unanimous: of 5 ratings, 2 are neutral.

→ Go deeper: the full Amn Healthcare Services, Inc. profile (consensus, analyst reliability, price target, performance).